Skip to main content
OpenTrials

Clinical trial condition

Anemia, Refractory

Explore clinical trials studying Anemia, Refractory. Study availability and eligibility vary by location and protocol.

188 public trials 35 recruiting studies
Refine in advanced search Browse all conditions

Anemia, Refractory trial results

Completed

Idarubicin, Cytarabine, and Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome

NCT00077116

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +16 more
Locations
  • AZ Sint-Jan Bruges, Belgium
  • Institut Jules Bordet Brussels, Belgium
  • Cliniques Universitaires Saint-Luc Brussels, Belgium
  • H. Hartziekenhuis - Roeselaere. Roeselare, Belgium
View Trial Details
Completed

Safety Study of MultiStem® in Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplasia

NCT00677859

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +12 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • University Hospitals Case Medical Center Cleveland, Ohio, United States
  • Oregon State University Medical Center Portland, Oregon, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions